Covid-19 has shaken world markets. One question likely to be on the minds of a lot of investors right now is how economic uncertainty caused by the pandemic will continue to affect large cap shares, such as the share price of Balchem (...
|Type||Buy / Hold / Sell|
|Year End 31st Dec||Unit||2016||2017||2018||2019||2020||2021E||2022E||CAGR / Avg|
|Diluted Normalised EPS|
|Op. Cashflow ps|
|Free Cashflow ps|
|Diluted Weighted Average Shares||m|
|Book Value ps|
|Leverage (ttm)||Total||- Intang||+ Pension|
|Cash / Assets|
Latest News & Insights for BCPC
Balchem Corporation is engaged in developing, manufacturing, distributing and marketing of specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. The Company operates through three business segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health (HNH) segment provides human grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications. HNH segment also serves the food and beverage industry for beverage, bakery, dairy, confectionary, and savory manufacturers. Its Animal Nutrition & Health (ANH) segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to basic choline chloride. The Specialty Products segment sells ethylene oxide as a sterilant gas primarily for use in the healthcare industry.
Latest News for BCPC
Upcoming Events for BCPC
Q4 2021 Balchem Corp Earnings Release
Q1 2022 Balchem Corp Earnings Release
Balchem Corp Annual Shareholders Meeting
As of Today at 18:15 UTC, shares in Balchem are trading at $149.75. This share price information is delayed by 15 minutes.
Shares in Balchem last closed at $149.75 and the price had moved by +22.6% over the past 365 days. In terms of relative price strength the Balchem share price has underperformed the S&P500 Index by -0.12% over the past year.
The overall consensus recommendation for Balchem is Buy. You can view the full broker recommendation list by unlocking its StockReport.
The Balchem dividend yield is 0.39% based on the trailing twelve month period.
Last year, Balchem paid a total dividend of $0.58, and it currently has a trailing dividend yield of 0.39%.Looking ahead, the next dividend pay date is 2022-01-21.
We do not have data on when Balchem is to next pay dividends. The historic dividend yield on Balchem shares is currently 0.39%.
To buy shares in Balchem you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $149.75, shares in Balchem had a market capitalisation of $4.85bn.
Here are the trading details for Balchem:
- Country of listing: United States
- Exchange: NSQ
- Ticker Symbol: BCPC
Based on an overall assessment of its quality, value and momentum Balchem is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Balchem is $169.67. That is 13.3% above the last closing price of $149.75.
Analysts covering Balchem currently have a consensus Earnings Per Share (EPS) forecast of $3.63 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Balchem. Over the past six months, its share price has outperformed the S&P500 Index by +9.2%.
As of the last closing price of $149.75, shares in Balchem were trading +4.93% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Balchem PE ratio based on its reported earnings over the past 12 months is 35.7. The shares last closed at $149.75.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Balchem's management team is headed by:
- Theodore Harris - CHM
- Martin Bengtsson - CFO
- James Hyde - SVP
- William Backus - CAO
- Mark Stach - GCN
- John Televantos - LED
- Kathleen Fish - DRC
- David Fischer - IND
- Daniel Knutson - IND
- Joyce Lee - IND
- Perry Premdas - IND
- Matthew Wineinger - IND